Switch from IL-5 to IL-5-Receptor alpha Antibody Treatment in Severe Eosinophilic Asthma

Drick, N; Milger, K; Seeliger, B; Fuge, J; Korn, S; Buhl, R; Schuhmann, M; Herth, F; Kendziora, B; Behr, J; Kneidinger, N; Bergmann, KC; Taube, C; Welte, T; Suhling, H

Suhling, H (corresponding author), Hannover Med Sch, Dept Resp Med, Hannover, Germany.

JOURNAL OF ASTHMA AND ALLERGY, 2020; 13 (): 605

Abstract

Background: Anti-IL-5 antibodies represent an established therapy for severe eosinophilic asthma (SEA), but some patients show inadequate response. Th......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索